DK120493B - Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf. - Google Patents

Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.

Info

Publication number
DK120493B
DK120493B DK507864AA DK507864A DK120493B DK 120493 B DK120493 B DK 120493B DK 507864A A DK507864A A DK 507864AA DK 507864 A DK507864 A DK 507864A DK 120493 B DK120493 B DK 120493B
Authority
DK
Denmark
Prior art keywords
benzylamines
halo
amino
preparation
acid addition
Prior art date
Application number
DK507864AA
Other languages
Danish (da)
English (en)
Inventor
J Keck
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Priority to DK631965A priority Critical patent/DK135037B/da
Publication of DK120493B publication Critical patent/DK120493B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK507864AA 1963-10-14 1964-10-14 Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf. DK120493B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK631965A DK135037B (da) 1963-10-14 1965-12-08 Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DET24890A DE1226115B (de) 1963-10-14 1963-10-14 Verfahren zur Herstellung von neuen Amino-halogen-benzylaminen
US40333964A 1964-10-12 1964-10-12
DET0028358 1965-04-09
GB54637/66A GB1154547A (en) 1963-10-14 1966-12-06 Substituted Benzylamines

Publications (1)

Publication Number Publication Date
DK120493B true DK120493B (da) 1971-06-07

Family

ID=27437631

Family Applications (2)

Application Number Title Priority Date Filing Date
DK507864AA DK120493B (da) 1963-10-14 1964-10-14 Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK631865AA DK116000B (da) 1963-10-14 1965-12-08 Fremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK631865AA DK116000B (da) 1963-10-14 1965-12-08 Fremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.

Country Status (11)

Country Link
US (1) US3336308A (pt)
JP (1) JPS4830044B1 (pt)
BE (2) BE654333A (pt)
CH (7) CH445516A (pt)
DE (2) DE1226115B (pt)
DK (2) DK120493B (pt)
FI (1) FI43998B (pt)
FR (3) FR1447971A (pt)
GB (3) GB1154547A (pt)
NL (2) NL6513188A (pt)
SE (2) SE312140B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3520930A (en) * 1964-12-31 1970-07-21 Merck & Co Inc Lower alkoxy-amino-benzylamines
DE1518372A1 (de) * 1965-04-09 1969-06-26 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-benzylaminen
US4018556A (en) * 1965-12-03 1977-04-19 Societe Anonyme Dite: L'oreal Hair dye compounds
DE1593579B1 (de) * 1966-05-10 1972-02-03 Thomae Gmbh Dr K Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung
US4073942A (en) * 1972-10-23 1978-02-14 Boehringer Ingelheim Gmbh Halo-substituted hydroxybenzyl-amines as secretolytic agents
US4101671A (en) * 1973-04-13 1978-07-18 Boehringer Ingelheim Gmbh Aminobenzyl-amines and salts thereof
US3882179A (en) * 1974-01-25 1975-05-06 Morton Norwich Products Inc 1-Veratrylamino-4-t-butylcyclohexylamine hydrochloride
IE40727B1 (en) * 1974-03-09 1979-08-01 Hoechst Ag Aralkylamines
DE3209429A1 (de) * 1982-03-16 1983-10-06 Boehringer Ingelheim Vetmed Mittel zur verbesserung der resorption von injizierten antibakteriell wirksamen substanzen und kombinationen, enthaltend ein benzyaminderivat
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
DE19529432C1 (de) * 1995-08-10 1997-05-15 Boehringer Ingelheim Kg Verfahren zur Herstellung von Benzylaminderivaten

Also Published As

Publication number Publication date
BE670767A (pt) 1966-04-12
FR4121M (pt) 1966-04-25
NL129966C (pt)
FR1447971A (fr) 1966-08-05
GB1054010A (pt)
CH460801A (de) 1968-08-15
SE312140B (pt) 1969-07-07
CH460802A (de) 1968-08-15
DE1518373B2 (de) 1973-11-29
FR5127M (pt) 1967-06-05
DE1226115B (de) 1966-10-06
NL6513188A (pt) 1966-04-13
BE654333A (pt) 1965-04-13
CH448120A (de) 1967-12-15
SE332181B (pt) 1971-02-01
GB1154547A (en) 1969-06-11
GB1052509A (pt)
US3336308A (en) 1967-08-15
CH460799A (de) 1968-08-15
FI43998B (pt) 1971-04-30
DK116000B (da) 1969-12-01
JPS4830044B1 (pt) 1973-09-17
DE1518373C3 (de) 1974-07-04
DE1518373A1 (de) 1969-12-18
CH445515A (de) 1967-10-31
CH445516A (de) 1967-10-31
CH460800A (de) 1968-08-15

Similar Documents

Publication Publication Date Title
DK125421B (da) Analogifremgangsmåde til fremstilling af 5-substituerede-aza-dibenzo-cycloheptener eller syreadditionssalte deraf.
DK108972C (da) Fremgangsmåde til fremstilling af lipoylpyridoxamin eller syreadditionssalte deraf.
DK108495C (da) Fremgangsmåde til fremstilling af substituerede 6,7-benzomorphaner eller syreadditionssalte deraf.
DK106733C (da) Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf.
DK120493B (da) Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK125701B (da) Analogifremgangsmåde til fremstilling af N-monosubstituerede 1-aminoindaner eller syreadditionssalte deraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK103831C (da) Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf.
DK106335C (da) Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf.
DK108394C (da) Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf.
DK113077B (da) Fremgangsmåde til fremstilling af basiske ethano-anthracenderivater eller syreadditionssalte deraf.
DK108973C (da) Fremgangsmåde til fremstilling af kinolinforbindelser eller syreadditionssaltene deraf.
DK121604B (da) Fremgangsmåde til fremstilling af substituerede iminocycloheptatrienderivater eller syreadditionssalte heraf.
DK108494C (da) Fremgangsmåde til fremstilling af basiske ketoner eller syreadditionssalte deraf.
DK105649C (da) Fremgangsmåde til fremstilling af 2-dimethylaminopyrazin eller syreadditionssalte deraf.
DK111893B (da) Fremgangsmåde til fremstilling af substituerede methylhydraziner eller syreadditionssalte deraf.
DK107098C (da) Fremgangsmåde til fremstilling af 5-hydrazino-pyrazol-derivater eller syreadditionssalte deraf.
DK122227B (da) Fremgangsmåde til fremstilling af 3-sulfamyl-4-halogen-benzamider eller syreadditionssalte heref.
DK112171B (da) Fremgangsmåde til fremstilling af benzimidazoler eller syreadditionssalte deraf.
DK119309B (da) Analogifremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf.
DK135037B (da) Analogifremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf.
DK123863B (da) Analogifremgangsmåde til fremstilling af N-monophenylethylneomycin B eller syreadditionssalte heraf.
DK112530B (da) Fremgangsmåde til fremstilling af α-phenyl-β-tetrahydofuryl-2-propionitriler eller syreadditionssalte heraf.
DK118241B (da) Fremgangsmåde til fremstilling af 2-amino-oxazoliner eller syreadditionssalte heraf.
DK107683C (da) Fremgangsmåde til fremstilling af 5-nitropyrrolderivater eller syreadditionssalte deraf.